Skip to content

Role of Snuhi-Paribhadra Kshar Sutra in Bhagandara(fistula-in-ano)

A clinical study of Snuhi-Paribhadra Kshar Sutra in Bhagandara(fistula-in-ano) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075671
Enrollment
30
Registered
2024-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K605- Anorectal fistula

Interventions

None listed

Sponsors

Vivek Khetwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical sign and symptoms of all types of Bhagandara (fistula-in-ano) irrespective of their sex, occupation and chronicity.Fresh as well as recurrent cases of Bhagandara.

Exclusion criteria

Exclusion criteria: HIV,HCV,HbsAg and veneral disease infected patients. Patient with gross co-morbidities and systemic illness such as CCF, MI, CRF, DM (uncontrolled). Osteomyelitis of femur or pelvic bones.Intestinal and pelvic malignancies. Pregnancy. Secondary fistula due to – Ulcerative colitis, Crohn’s disese, Tuberculosis.

Design outcomes

Primary

MeasureTime frame
The improvement will be assessed based on: 1. Swelling (Mild, Moderate,Severe and very severe) 2.Itching(Mild,Moderate,Severe and very severe) 3.Pain(Mild,Moderate,Severe and very severe) 4.Discharge(Mild,Moderate,Severe and very severe) 5.Burning sensation(Mild,Moderate,Severe and very severe) 6.inflammation(Mild,Moderate,Severe and very severe)Timepoint: Kshar Sutra will be changed after 7 days and an assessment will be sought after every 1 week,4 weeks,and 8 weeks.

Secondary

MeasureTime frame
Exacerbation in Pain,burning sensation,itching & discharge.Timepoint: Approx 1 week,4 weeks & 8 weeks.

Countries

India

Contacts

Public ContactVivek Khetwal

Gurukul campus Haridwar

drpankajsharma21@yahoo.com9927067792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026